Siemens Healthineers Stock
Siemens Healthineers AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Germany
- CEO
- Bernhard Montag
- Employees
- 74,300
- Market cap
- €46.4 B
- IPO
- 12/04/2018
Siemens Healthineers AG is a global leader in medical technology within the healthcare sector. Headquartered in Forchheim, Germany, and led by CEO Bernhard Montag, the company develops, produces, and distributes a comprehensive portfolio of diagnostic and therapeutic products and services for healthcare providers…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Siemens Healthineers stock: price history
1D
+1.5%
1W
+5.9%
1M
+8.1%
6M
+6.5%
YTD
-7.7%
1Y
-12.9%
2Y
-20.1%
5Y
-27.7%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~42% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Siemens Healthineers stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Siemens Healthineers
Analyst assessment of Siemens Healthineers
0
STRONG BUY
1
BUY
1
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 08/09/2021
Siemens Healthineers stock metrics
P/E
20.93
P/B
2.43
EV/EBITDA
13.05
RETURN ON EQUITY
3.5%
NET MARGIN
11.6%
DEBT/EQUITY
0.79
DIVIDEND YIELD
2.4%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
32.0%
FLOAT SHARES
358,007,130
AVG. DAILY VOLUME (30D)
932,525
Dividends
Comparable stocks
Frequently asked questions about Siemens Healthineers stock
What does Siemens Healthineers do?
Siemens Healthineers AG is a company in the Healthcare sector, Medical - Devices industry, headquartered in Germany.
The CEO is Bernhard Montag, the company employs around 74,300 people.
The IPO was on 12/04/2018; the stock trades on XETRA under the ticker SHL.DE.
What do analysts say about Siemens Healthineers stock?
2 analysts rate the stock, the consensus is Buy (as of 08/09/2021).
This is an external assessment, not a statement by Market Jury.
When does Siemens Healthineers report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 42% stronger than usual.
Does Siemens Healthineers pay a dividend?
Yes. The last dividend was €1.00 per share, ex-date 06/02/2026, paid on 10/02/2026.
The dividend yield is 2.4% (as of 30/06/2026).
Which stocks are comparable to Siemens Healthineers?
Comparable stocks include Drägerwerk, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, DexCom and GE HealthCare Technologies.
How can I get Siemens Healthineers stock analyzed?
Clicking "Analyze stock" lets five strategies assess Siemens Healthineers against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.